收藏切换
Serum metabolomics study of ADB-BUTINACA intervention in rats based on UHPLC-Q-Orbitrap-HRMS
收藏切换
PDF
Hao CHEN1, Hao-zhe XU1, Hao WU2, Xing KE1, Sen ZHAO1, Yi-lei FAN1, *, Jing ZHOU1, *
Acta Pharmaceutica Sinica | 2025, 60(4) : 1074 - 1083
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(4): 1074-1083
Original Articles
Serum metabolomics study of ADB-BUTINACA intervention in rats based on UHPLC-Q-Orbitrap-HRMS
Full
Hao CHEN1, Hao-zhe XU1, Hao WU2, Xing KE1, Sen ZHAO1, Yi-lei FAN1, *, Jing ZHOU1, *
Affiliations
  • 1Key Laboratory of Drug Prevention and Control Technology of Zhejiang Province, Zhejiang Police College, Hangzhou 310052, China
  • 2Dian Regional Forenic Science Institute·Zhejiang, Hangzhou 310007, China
Published: 2025-04-12 doi: 10.16438/j.0513-4870.2024-0669
Outline
收藏切换

Synthetic cannabinoid N-(1-carbamoyl-2, 2-dimethylpropyl)-1-butylazole-3-formamide (ADB-BUTINACA), as a new psychoactive substance, shows strong stimulant and hallucinogenic effects. It can cause cardiovascular, renal and gastrointestinal diseases, and in severe cases, it can lead to death. However, there are few reports on toxicology studies of the ADB-BUTINACA metabolic pathway and its long-term effects on the organism and the molecular mechanisms behind it. In this study, the metabolic profile of rat serum after low, medium and high doses of ADB-BUTINACA (0.1, 1, and 5 mg·kg-1) intervention were analyzed using UHPLC coupled with a Q-Orbitrap-MS (UHPLC-Q-Orbitrap-HRMS). The results showed that the intervention of ADB-BUTINACA could cause significant changes of 50 metabolites such as L-glutamate and 3-hydroxybutyrate, and nine metabolic pathways including alanine, aspartate and glutamate metabolism, retinol metabolism, and TCA cycle were disturbed. These findings provide a novel experimental and theoretical framework for further investigation of the toxicological mechanisms underlying ADB-BUTINACA-induced dysregulation of lipid and energy metabolism. Furthermore, they offer valuable insights that could facilitate the diagnosis and prevention of ADB-BUTINACA toxicity, thereby underscoring their significant implications for public health. The study was conducted in adherence to both the Declaration of Helsinki and the National Institutes of Health's Guidelines for the Care and Use of Laboratory Animals, and received approval from the animal experimental center at the Zhejiang Chinese Medical University (Ethical number: 20220718-11).

synthetic cannabinoid  /  N-(1-carbamoyl-2, 2-dimethylpropyl)-1-butylazole-3-formamide  /  serum  /  non-targeted metabolomics  /  UHPLC-Q-Orbitrap-HRMS
Hao CHEN, Hao-zhe XU, Hao WU, Xing KE, Sen ZHAO, Yi-lei FAN, Jing ZHOU. Serum metabolomics study of ADB-BUTINACA intervention in rats based on UHPLC-Q-Orbitrap-HRMS[J]. Acta Pharmaceutica Sinica, 2025 , 60 (4) : 1074 -1083 . DOI: 10.16438/j.0513-4870.2024-0669
Year 2025 volume 60 Issue 4
PDF
188
74
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0669
  • Receive Date:2024-07-15
  • Online Date:2025-10-29
  • Published:2025-04-12
Article Data
Affiliations
History
  • Received:2024-07-15
  • Revised:2024-12-23
Funding
Affiliations
    1Key Laboratory of Drug Prevention and Control Technology of Zhejiang Province, Zhejiang Police College, Hangzhou 310052, China
    2Dian Regional Forenic Science Institute·Zhejiang, Hangzhou 310007, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0669
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT